ATE279914T1 - Oral anzuwendendes arzneimittel zur wirkstoffverabreichung im magendarmtrakt - Google Patents

Oral anzuwendendes arzneimittel zur wirkstoffverabreichung im magendarmtrakt

Info

Publication number
ATE279914T1
ATE279914T1 AT99972918T AT99972918T ATE279914T1 AT E279914 T1 ATE279914 T1 AT E279914T1 AT 99972918 T AT99972918 T AT 99972918T AT 99972918 T AT99972918 T AT 99972918T AT E279914 T1 ATE279914 T1 AT E279914T1
Authority
AT
Austria
Prior art keywords
layer
drug
gitric
administration
active ingredients
Prior art date
Application number
AT99972918T
Other languages
English (en)
Inventor
Kanji Takada
Original Assignee
Kanji Takada
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kanji Takada filed Critical Kanji Takada
Application granted granted Critical
Publication of ATE279914T1 publication Critical patent/ATE279914T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
AT99972918T 1998-11-27 1999-11-26 Oral anzuwendendes arzneimittel zur wirkstoffverabreichung im magendarmtrakt ATE279914T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP35396698 1998-11-27
JP26643399 1999-09-21
PCT/JP1999/006602 WO2000032172A1 (en) 1998-11-27 1999-11-26 An oral formulation for gastrointestinal drug delivery

Publications (1)

Publication Number Publication Date
ATE279914T1 true ATE279914T1 (de) 2004-11-15

Family

ID=26547440

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99972918T ATE279914T1 (de) 1998-11-27 1999-11-26 Oral anzuwendendes arzneimittel zur wirkstoffverabreichung im magendarmtrakt

Country Status (17)

Country Link
US (1) US7097851B1 (de)
EP (1) EP1135112B1 (de)
JP (1) JP4497725B2 (de)
KR (1) KR100762475B1 (de)
CN (1) CN1161107C (de)
AT (1) ATE279914T1 (de)
AU (1) AU766293B2 (de)
BR (1) BR9916871A (de)
CA (1) CA2352389C (de)
DE (1) DE69921353T2 (de)
DK (1) DK1135112T3 (de)
ES (1) ES2233106T3 (de)
HK (1) HK1043545A1 (de)
ID (1) ID29085A (de)
IL (1) IL143356A0 (de)
MX (1) MXPA01005346A (de)
WO (1) WO2000032172A1 (de)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60143571D1 (de) * 2000-05-26 2011-01-13 Kanji Takada Nicht-orale zubereitung mit einer dreischicht-struktur
JP2004525110A (ja) * 2001-02-16 2004-08-19 清水製薬株式会社 ムコ多糖類製剤およびその製造法
DE10120092B4 (de) * 2001-04-25 2008-03-20 Lts Lohmann Therapie-Systeme Ag Magensaftresistente Vorrichtung zur Freisetzung von mukoadhäsiven Wirkstoffträgern und Verfahren zur Herstellung der magensaftresistenten Vorrichtung
US20030017195A1 (en) * 2001-07-20 2003-01-23 Samir Mitragotri Method for oral drug delivery
US6585997B2 (en) * 2001-08-16 2003-07-01 Access Pharmaceuticals, Inc. Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
WO2003026699A1 (fr) * 2001-09-26 2003-04-03 Tanabe Seiyaku Co., Ltd. Compositions medicinales favorisant l'absorption de medicaments
US20060034929A1 (en) * 2001-12-27 2006-02-16 Brubaker Michael J Sustained release drug delivery devices with prefabricated permeable plugs
US7200424B2 (en) 2002-07-15 2007-04-03 Bellsouth Intelectual Property Corporation Systems and methods for restricting the use and movement of telephony devices
US8554187B2 (en) 2002-07-15 2013-10-08 At&T Intellectual Property I, L.P. Apparatus and method for routing communications between networks and devices
US8275371B2 (en) * 2002-07-15 2012-09-25 At&T Intellectual Property I, L.P. Apparatus and method for providing communications and connection-oriented services to devices
US8526466B2 (en) 2002-07-15 2013-09-03 At&T Intellectual Property I, L.P. Apparatus and method for prioritizing communications between devices
US8543098B2 (en) 2002-07-15 2013-09-24 At&T Intellectual Property I, L.P. Apparatus and method for securely providing communications between devices and networks
TWI355276B (en) * 2003-01-14 2012-01-01 Akira Tsuji Gastrointestinal absorption enhancer mediated by p
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
CA2544678C (en) 2003-11-05 2013-12-31 Sunesis Pharmaceuticals, Inc. Modulators of cellular adhesion
KR100638041B1 (ko) * 2003-12-24 2006-10-23 주식회사 삼양사 수용성 약물의 경구투여용 나노입자 조성물 및 그의제조방법
JP4606748B2 (ja) * 2004-02-06 2011-01-05 京セラケミカル株式会社 固形製剤の製造方法
PE20060003A1 (es) * 2004-03-12 2006-03-01 Smithkline Beecham Plc Formulacion farmaceutica polimerica para moldear por inyeccion
AT502098B8 (de) 2004-07-07 2007-06-15 Albert Dr Missbichler Diaminooxidase-hältige zusammensetzung
JP2008516893A (ja) * 2004-08-27 2008-05-22 スフェリックス，インク． 多層錠剤および生体接着性剤形
JP4787503B2 (ja) * 2005-01-12 2011-10-05 京セラケミカル株式会社 固形製剤の製造方法
JP4787507B2 (ja) * 2005-01-24 2011-10-05 京セラケミカル株式会社 固形製剤及びその製造方法
JP2008155067A (ja) * 2005-04-14 2008-07-10 Toray Eng Co Ltd マイクロカプセル製造方法、マイクロカプセル製造装置、およびマイクロカプセルシート
DK2444079T3 (en) 2005-05-17 2017-01-30 Sarcode Bioscience Inc Compositions and Methods for the Treatment of Eye Diseases
DE112007000162T5 (de) * 2006-01-19 2008-11-27 Toray Engineering Co., Ltd. Laminiertes Mikrokapselblatt und Verfahren zu deren Herstellung
JP2007246412A (ja) * 2006-03-14 2007-09-27 Serubakku:Kk 消化管用経口製剤とその製造方法および消化管用経口カプセル剤
US20100136123A1 (en) * 2006-10-12 2010-06-03 Toray Engineering Co., Ltd. Microcapsule Sheet
AU2008238634B2 (en) * 2007-03-30 2013-01-17 Lintec Corporation Film-like orally administered medication and manufacturing method therefor
US20100303901A1 (en) * 2007-04-26 2010-12-02 Eyal Shimoni Oral delivery of proteins and peptides
US8707964B2 (en) * 2007-10-31 2014-04-29 The Invention Science Fund I, Llc Medical or veterinary digestive tract utilization systems and methods
US20090105561A1 (en) * 2007-10-17 2009-04-23 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Medical or veterinary digestive tract utilization systems and methods
US8789536B2 (en) 2007-10-17 2014-07-29 The Invention Science Fund I, Llc Medical or veterinary digestive tract utilization systems and methods
US8303573B2 (en) 2007-10-17 2012-11-06 The Invention Science Fund I, Llc Medical or veterinary digestive tract utilization systems and methods
ES2830024T3 (es) 2007-10-19 2021-06-02 Novartis Ag Composiciones y métodos para el tratamiento del edema macular
US8808276B2 (en) * 2007-10-23 2014-08-19 The Invention Science Fund I, Llc Adaptive dispensation in a digestive tract
US8109920B2 (en) * 2007-10-31 2012-02-07 The Invention Science Fund I, Llc Medical or veterinary digestive tract utilization systems and methods
US8333754B2 (en) * 2007-10-31 2012-12-18 The Invention Science Fund I, Llc Medical or veterinary digestive tract utilization systems and methods
US8808271B2 (en) * 2007-10-31 2014-08-19 The Invention Science Fund I, Llc Medical or veterinary digestive tract utilization systems and methods
US20090163894A1 (en) * 2007-10-31 2009-06-25 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Medical or veterinary digestive tract utilization systems and methods
US20090137866A1 (en) * 2007-11-28 2009-05-28 Searete Llc, A Limited Liability Corporation Of The State Delaware Medical or veterinary digestive tract utilization systems and methods
WO2009139817A2 (en) 2008-04-15 2009-11-19 Sarcode Corporation Crystalline pharmaceutical and methods of preparation and use thereof
PE20110543A1 (es) 2008-08-15 2011-08-04 Ironwood Pharmaceuticals Inc Formulacion solida oral que comprende linaclotida, cation de calcio y leucina
CA2770077A1 (en) 2009-08-06 2011-02-10 Ironwood Pharmaceuticals, Inc. Formulations comprising linaclotide
WO2011050175A1 (en) 2009-10-21 2011-04-28 Sarcode Corporation Crystalline pharmaceutical and methods of preparation and use thereof
AU2010339907A1 (en) 2009-12-16 2012-07-05 Nod Pharmaceuticals, Inc. Compositions and methods for oral drug delivery
US20110142889A1 (en) * 2009-12-16 2011-06-16 Nod Pharmaceuticals, Inc. Compositions and methods for oral drug delivery
UA108636C2 (xx) 2010-02-17 2015-05-25 Пептид
EP2603232B1 (de) 2010-08-11 2019-09-25 Ironwood Pharmaceuticals, Inc. Stabile linaclotidformulierungen
CN103153289B (zh) * 2010-08-25 2016-08-31 格兰特·鲁弗斯·斯柏林二世 改进型肠溶活性物质给药
US9808418B2 (en) 2010-11-26 2017-11-07 University Of The Witwatersrand, Johannesburg Pharmaceutical dosage form
MX347354B (es) 2011-08-17 2017-04-24 Ironwood Pharmaceuticals Inc Tratamientos para trastornos gastrointestinales.
WO2014018075A1 (en) 2012-07-23 2014-01-30 Crayola, Llc Dissolvable films and methods of using the same
KR20200108932A (ko) 2012-07-25 2020-09-21 에스에이알코드 바이오사이언스 인코포레이티드 Lfa-1 저해제 및 그의 다형체
WO2019004088A1 (ja) * 2017-06-27 2019-01-03 株式会社バイオセレンタック 粘膜付着性経口製剤

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4451260A (en) * 1982-03-26 1984-05-29 Minnesota Mining And Manufacturing Company Sustained release oral medicinal delivery device
US4767627A (en) * 1985-05-29 1988-08-30 Merck & Co., Inc. Drug delivery device which can be retained in the stomach for a controlled period of time
JPS61280423A (ja) * 1985-06-05 1986-12-11 Kiyuukiyuu Yakuhin Kogyo Kk 口腔内粘膜貼付剤
JPH07121859B2 (ja) * 1986-03-18 1995-12-25 第一製薬株式会社 徐放性カプセル剤
US5196202A (en) * 1986-09-01 1993-03-23 Teikoku Seiyaku Kabushiki Kaisha Sustained release dosage form
US5236713A (en) 1987-10-21 1993-08-17 Teikoku Seiyaku Kabushiki Kaisha Preparation for intermittently releasing active agent applicable to oral cavity
US5350741A (en) 1988-07-30 1994-09-27 Kanji Takada Enteric formulations of physiologically active peptides and proteins
BR9205864A (pt) * 1991-04-08 1994-06-28 Sumitomo Pharma Formulações sólidas porosas contendo substâncias proteináceas fisiologicamente ativas.
US5686105A (en) * 1993-10-19 1997-11-11 The Procter & Gamble Company Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
WO1995005416A2 (en) * 1993-08-19 1995-02-23 Cygnus Therapeutic Systems Water-soluble pressure-sensitive mucoadhesive and devices provided therewith for emplacement in a mucosa-lined body cavity
US5637319A (en) 1995-03-01 1997-06-10 Takada; Kanji Controlled-release preparations
AUPN605795A0 (en) * 1995-10-19 1995-11-09 F.H. Faulding & Co. Limited Analgesic pharmaceutical composition
US6231888B1 (en) * 1996-01-18 2001-05-15 Perio Products Ltd. Local delivery of non steroidal anti inflammatory drugs (NSAIDS) to the colon as a treatment for colonic polyps
DE19646392A1 (de) * 1996-11-11 1998-05-14 Lohmann Therapie Syst Lts Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht
EP0878200B1 (de) * 1996-11-22 2003-05-21 Toray Industries, Inc. Therapeutischer wirkstoff für augenerkrankungen
WO1998024412A2 (en) * 1996-12-05 1998-06-11 The Board Of Trustees Of The University Of Illinois Compounds useful against diseases of the colon and methods for orally administering same
EP1053752A1 (de) * 1998-02-10 2000-11-22 Yoshitomi Pharmaceutical Industries, Ltd. Zubereitungen mit gesteuerter freisetzung

Also Published As

Publication number Publication date
HK1043545A1 (zh) 2002-09-20
BR9916871A (pt) 2001-08-21
DK1135112T3 (da) 2005-02-14
CN1333680A (zh) 2002-01-30
JP4497725B2 (ja) 2010-07-07
EP1135112B1 (de) 2004-10-20
EP1135112A1 (de) 2001-09-26
ES2233106T3 (es) 2005-06-01
ID29085A (id) 2001-07-26
AU766293B2 (en) 2003-10-16
KR100762475B1 (ko) 2007-10-04
US7097851B1 (en) 2006-08-29
AU1410100A (en) 2000-06-19
DE69921353T2 (de) 2005-11-10
CN1161107C (zh) 2004-08-11
JP2002531394A (ja) 2002-09-24
IL143356A0 (en) 2002-04-21
DE69921353D1 (de) 2004-11-25
KR20010086057A (ko) 2001-09-07
WO2000032172A1 (en) 2000-06-08
MXPA01005346A (es) 2003-03-27
CA2352389A1 (en) 2000-06-08
CA2352389C (en) 2009-01-20

Similar Documents

Publication Publication Date Title
ATE279914T1 (de) Oral anzuwendendes arzneimittel zur wirkstoffverabreichung im magendarmtrakt
CA2219991A1 (en) Taste masking pharmaceutical composition for oral administration
ATE261301T1 (de) Arzneizubereitungen enthaltend nicht-steroidale entzündungshemmende arzneimittel
WO2004054542A3 (en) Oral drug delivery system comprising high viscosity liquid carrier materials
AU1488295A (en) Pharmaceutical composition
WO1998056360A3 (en) Film-coated tablet for improved upper gastrointestinal tract safety
CA2329005A1 (en) Folic acid-containing pharmaceutical compositions, and related methods and delivery systems
WO2006102446A3 (en) Multi-particulate, modified-released colonic composition
AU2879100A (en) Formulation and system for intra-oral delivery of pharmaceutical agents
CA2181502A1 (en) Pharmaceutical preparation in form of coated capsule releasable at lower part of digestive tract
CA2240329A1 (en) Improved delivery of multiple doses of medications
WO2007079082A3 (en) Gastric release pulse system for drug delivery
MX9804008A (es) Formulaciones farmaceuticas.
AU2001283563A1 (en) Oral pharmaceutical dosage forms for pulsatile delivery of an antiarrhythmic agent
DE3686936D1 (de) Am zielorgan wirkendes enterales abgabesystem.
WO2005046640A3 (en) Multi-site drug delivery platform
GEP20033014B (en) Enteric Coated Pharmaceutical Composition and Method of Manufacturing
AU3345197A (en) Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof
EE05506B1 (et) Ravimi manustamise vahend eriti progestiinide ja”strogeenide manustamiseks
WO2001041742A3 (en) Antiviral medication
EP2497466A3 (de) Präparat zur oralen Verabreichung
EP2474307A3 (de) System zur Verabreichung proliposomaler Arzneimittel
EP1749540A3 (de) Zuberbeitungen zur Erhöhung der Bioverfügbarkeit von oral verabreichten pharmazeutischen Verbindungen
FI20000780A7 (fi) Peroraalinen lääkemuoto lääkeaineen hallituksi vapauttamiseksi
WO2006060325A3 (en) Coated drug delivery formulations

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties